Literature DB >> 19183083

The controversy on screening for intimate partner violence: a question of semantics?

Joanne Klevens1, Linda E Saltzman.   

Abstract

In this paper, we review the basis of the U.S. Preventive Services Task Force's recommendations related to routine screening for intimate partner violence (IPV), focus on two of the arguments of those who have rejected these recommendations, and based on these, suggest that this controversy has occurred, in part, as a result of different interpretations of the meaning of "screening." We differentiate screening from situations in which asking about IPV is essential for differential diagnosis, that is, exploring exposure to IPV when there are signs and symptoms that might result from this exposure. Finally, we describe the randomized, controlled trial CDC is conducting to contribute to the evidence the U.S. Preventive Services Task Force requries to make its recommendations.

Mesh:

Year:  2009        PMID: 19183083     DOI: 10.1089/jwh.2008.1252

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  4 in total

1.  Is Spanish language a barrier to domestic violence assessment?

Authors:  Aminah Jatoi; Carmen Radecki Breitkopf
Journal:  J Womens Health (Larchmt)       Date:  2011-06-01       Impact factor: 2.681

2.  Policymaking Under Uncertainty: Routine Screening for Intimate Partner Violence.

Authors:  Rada K Dagher; Mary A Garza; Katy Backes Kozhimannil
Journal:  Violence Against Women       Date:  2014-07-10

3.  Possibilities and hindrances for prevention of intimate partner violence: perceptions among professionals and decision makers in a Swedish medium-sized town.

Authors:  A Jakobsson; C von Borgstede; G Krantz; F Spak; G Hensing
Journal:  Int J Behav Med       Date:  2013-09

4.  The role of the healthcare sector in the prevention of sexual violence against sub-Saharan transmigrants in Morocco: a study of knowledge, attitudes and practices of healthcare workers.

Authors:  Seline van den Ameele; Ines Keygnaert; Alima Rachidi; Kristien Roelens; Marleen Temmerman
Journal:  BMC Health Serv Res       Date:  2013-02-25       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.